Sustanon is a trade name owned by Organon Pharmaceuticals for oil-based injectable blends of esterized testosterone compounds.
Sustanon 250 is a blend of four esterized testosterone compounds:
Sustanon 100 was similar, though with three esters. This smaller dose was usually for pediatric use.
Androgen/testosterone-replacement therapy might be suggested for male patients suffering from hypogonadism. The following hypogonadal disorders could call for treatment using Sustanon 350: eunuchoidism, hypopituitarism and castration. Testosterone-replacement therapy may also be indicated because of male androgen/testosterone deficiency. The drug may also be employed as supportive therapy for female-to-male transsexuals .
CONTACT AS -: 7777041032 / 33 / 31